News
Privately-held California, USA-based drug developer Ashvattha Therapeutics announced positive top-line end-of-study results ...
Chicago-based private equity firm GTCR has agreed to acquire Czech generic drugmaker Zentiva from Advent International in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results